文摘
The content of isoflavones and residual activities of soybean trypsin (SBTI) and chymotrypsin (SBCI) inhibitors in the major soymilks and soy-based infant formulas sold in Ottawa, Canada were examined. The residual SBTI activities ( % whole soybean) measured as the ability to inhibit the release of p-nitroaniline from N-benzoyl-dl-arginine-p-nitroanilide by trypsin were from 6.4 % to 55.6 % in soymilks (8 brands), 4.2 % to 8.8 % in liquid formulas (4 brands) and 1.9 % to 5.1 % in powdered formulas (8 brands). SBCI activities ( % whole soybean) measured as the ability to inhibit the degradation of casein by chymotrypsin in soymilks were from 3.5 % to 33.7 % . Total isoflavones measured as aglycones were from 26.4 ¡À 0.18 to 55.3 ¡À 3.48 ¦Ìg/g wet weight in liquid formulas or 137.5 ¡À 3.0 to 229.1 ¡À 2.3 ¦Ìg/g dry weight in powdered formulas and 49.8 ¡À 0.5 to 279.9 ¡À 3.4 ¦Ìg/g wet weight in soymilks. Compared to soymilks, the residual SBTI activities and total isoflavones in infant formulas were lower. The residual SBTI activities in 6 out of the 8 soymilks measured were higher than the level (10 % ) considered being safe.